Detalhe da pesquisa
1.
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.
Lancet
; 401(10373): 294-302, 2023 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709074
2.
Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells.
J Immunol
; 201(12): 3804-3814, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413671
3.
Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial.
JAMA
; 323(14): 1369-1377, 2020 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32286643
4.
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.
Lancet
; 391(10120): 552-562, 2018 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217376
5.
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.
J Infect Dis
; 215(1): 95-104, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28077588
6.
A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men.
J Infect Dis
; 214(9): 1341-1348, 2016 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27521362
7.
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.
Lancet Infect Dis
; 22(8): 1210-1220, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568049
8.
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).
J Infect Dis
; 201(4): 600-7, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20078213
9.
Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials.
Afr J Lab Med
; 10(1): 1056, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33833946
10.
Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variants.
J Virol
; 82(6): 2853-66, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18184702
11.
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial.
Lancet HIV
; 6(4): e230-e239, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30885692
12.
Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy.
Vaccine
; 35(15): 1898-1906, 2017 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28285985
13.
CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
BMC Immunol
; 7: 8, 2006 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-16620386
14.
Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2.
AIDS Res Hum Retroviruses
; 22(7): 695-702, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16831094
15.
Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibition.
AIDS
; 30(11): 1703-12, 2016 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27088318
16.
Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.
Mol Ther Methods Clin Dev
; 3: 16061, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27617268
17.
HIV-1 MN Env 15-mer peptides better detect HIV-1 specific CD8 T cell responses compared with consensus subtypes B and M group 15-mer peptides.
AIDS
; 19(11): 1165-72, 2005 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-15990569
18.
Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials.
AIDS Res Hum Retroviruses
; 21(1): 68-81, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15665646
19.
Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected Ethiopians.
AIDS Res Hum Retroviruses
; 21(3): 239-45, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15795531
20.
Standardization and validation issues of the ELISPOT assay.
Methods Mol Biol
; 302: 51-86, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15937345